参考文献/References:
[1] 康玉华,杨 宇,王宝家,等.肝纤维化动物模型的研究进展[J].辽宁中医杂志,2016,43(10):2229-2231.
[2] Mudda J,Bajaj M.Stem cell therapy:a challenge to periodontist[J].Indian J Dent Res,2011,22(1):132-139.
[4] van der Meer AJ,Hansen BE,Fattovich G,et al.Reliable prediction of clincal outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis:a validated model using objective and readily available clinical parameters[J].Gut,2015,64(2):322-331.
[4] 郑旭锐,张选国,宋 健,等.姜黄素对肝纤维化模型肝组织Ⅳ型胶原和转化生长因子β1mRNA表达的影响[J].陕西中医,2009,30(6):749-750.
[5] Askari F,Dick R,Mao M,et al.Tetrathiomolybdate therapy protects against concanavalin a and carbon tetrachloride hepatic damage in mice[J].Exp Biol Med,2004,229(8):857-863.
[6] Raetsch C,Jia JD,Boigk G,et al.Pentoxifylline downregulates profibrogenic cytokines and procollagen Ⅰ expression in rat secoldary biliary fibrosis[J].Gut,2002,50(2):241-247.
[7] 牛天宇.苦参素衍生物的设计、合成及抗肝纤维化活性研究[D].北京:北京协和医学院,2019.
[8] Ochi T,Kawakita T,Nomoto K.Effects of Hochu-ekki-to and Ninjin-youei-to,traditional Japanese medicines,on porcine serum-induced liver fibrosis in rats[J].Immunopharmacol Immunotoxicol,2004,26(2):285-298.
[9] 张福奎,王宝恩,王泰龄,等.实验性肝纤维化时肝内纤维及血管的三维结构观察及复方中药对其影响[J].中华肝脏病杂志,2000(06):355-357.
[10] Coutinho EM.Malnutrition and hepatic fibrosis in murine schistosomiasis[J].Mem Inst Oswaldo Cruz,2004,99(5):85-92.
[11] 杨 媛.CHOP/KLF4在血吸虫致肝纤维化中的表达及意义[D].荆州:长江大学,2018.
[12] Guangfu X,Pengtao L,Xinyue W,et al.Dynamic changes in the expression of matrix metalloproteinases and their inhibitors,TIMPs,during hepatic fibrosis induced by alcohol in rats[J].World J Gastroenterol,2004,10(24):3621-3627.
[13] Milani S,Herbst H,Schuppan D,et al.In situ hybridization for procollagen types Ⅰ,Ⅲand Ⅳ mRNA in normal and fibrotic rat liver:evidence for predominant expression in non-parenchymal liver cells[J].Hepatology,1989,10:84-92.
[14] 薛红安,聂青和,王 媛,等.肝康合剂实验性治疗大鼠肝纤维化的分子机制研究[J].陕西医学杂志,2009,38(9):1128-1131,1183.
[15] 柯跃斌,郑荣梁.自由基毒理学[M].北京:人民卫生出版社,2012:7-50.
[16] 华 忠.四氯化碳致大鼠肝纤维化模型的研究进展[A].中国中西医结合学会传染病专业委员会.全国第2届中西医结合传染病学术会议暨国家中医药管理局第1届传染病协作组会议论文汇编[C].北京:中国中西医结合学会传染病专业委员会:中国中西医结合学会,2008:4.
[17] 明盛金,尹彬彬,李 俊,等.复合因素法致大鼠肝纤维化模型的建立[J].吉林医药学院学报,2012,33(6):358-360.
相似文献/References:
[1]徐志刚,曹 罡,程传涛,等.CTRP3通过TGF-β1/Smad 信号通路减弱肝星状细胞活性机制研究*[J].陕西医学杂志,2020,49(5):523.
XU Zhigang,CAO Gang,CHENG Chuantao,et al.Mechanism of CTRP3 attenuating hepatic stellate cell activation through TGF-β1/Smad signal pathway[J].,2020,49(6):523.
[2]刘 宾,崔 鑫,秦傲霜,等.封闭式负压治疗对改善美容缝合伤口愈合质量的实验研究*[J].陕西医学杂志,2020,49(5):553.
LIU Bin,CUI Xin,QIN Aoshuang,et al.Effect of closed negative pressure therapy on improving the quality of cosmetic suture wound healing[J].,2020,49(6):553.
[3]刘翔宇,王凌云.环杷明抑制肝星形细胞激活改善肝纤维化作用实验研究*[J].陕西医学杂志,2020,49(6):663.[doi:DOI:10.3969/j.issn.10007377.2020.06.006]
LIU Xiangyu,WANG Lingyun..Effect of cyclopamine on inhibiting the activation of hepatic astrocyte and improving hepatic fibrosis[J].,2020,49(6):663.[doi:DOI:10.3969/j.issn.10007377.2020.06.006]
[4]张荣臻,吕 超,石清兰,等.急性肝衰竭大鼠模型构建实验研究[J].陕西医学杂志,2021,50(3):268.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.003]
ZHANG Rongzhen,LYU Chao,SHI Qinglan,et al.Construction of rat model of acute liver failure[J].,2021,50(6):268.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.003]
[5]韩艳珍,单铁英,李 伟,等.口服枸杞多糖对小鼠肝纤维化组织基质金属蛋白酶-2及基质金属蛋白酶-2抑制剂水平影响的实验研究[J].陕西医学杂志,2021,50(3):276.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.005]
HAN Yanzhen,SHAN Tieying,LI Wei,et al.Effects of Lycium barbarum polysaccharide on the levels of MMP-2 and TIMP-2 in mice with liver fibrosis[J].,2021,50(6):276.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.005]
[6]陈 丹,王文静,王庆雅,等.生物发光成像技术在肿瘤细胞活体可视化研究中的应用研究进展[J].陕西医学杂志,2022,51(1):111.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.028]
CHEN Dan,WANG Wenjing,WANG Qingya,et al.Application of bioluminescence imaging technology in visualization of cancer cells in vivo[J].,2022,51(6):111.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.028]
[7]曾德优,张六一,肖 创,等.慢性阻塞性肺疾病动物模型研究进展[J].陕西医学杂志,2022,51(4):507.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.029]
ZENG Deyou,ZHANG Liuyi,XIAO Chuang,et al.Research progress on animal models of chronic obstructive pulmonary disease[J].,2022,51(6):507.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.029]
[8]姜 帆,李春香,李忠原.超声双模态影像技术联合动态增强磁共振检查对大鼠早期肝纤维化的评估价值实验研究[J].陕西医学杂志,2023,52(3):273.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.006]
JIANG Fan,LI Chunxiang,LI Zhongyuan.Evaluation value of ultrasound dual-modality imaging technique combined with DCE-MRI in rats with early hepatic fibrosis[J].,2023,52(6):273.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.006]
[9]刘 俊,曾 龙,高 云,等.长链非编码RNA YAF2-AS1通过调控微小RNA-141-3p表达抑制肝星状细胞活化实验研究[J].陕西医学杂志,2023,52(9):1120.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.002]
LIU Jun,ZENG Long,GAO Yun,et al.Long-chain non-coding RNA YAF2-AS1 inhibits activation of hepatic stellate cells by regulating expression of microRNA-141-3p[J].,2023,52(6):1120.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.002]
[10]郝礼森,潘恩亮,季景秀,等.含SH2结构域蛋白酪氨酸磷酸酶2表达变化对肝纤维化大鼠肝组织中细胞外信号调节激酶1/2活性的影响[J].陕西医学杂志,2023,52(12):1642.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.004]
HAO Lisen,PAN Enliang,JI Jingxiu,et al.Effects of SHP2 expression changes on ERK1/2 activity in liver tissues of rats with hepatic fibrosis[J].,2023,52(6):1642.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.004]
[11]艾丁丁,罗伟生△,蒋云霞.动物肝纤维化模型建立研究进展*[J].陕西医学杂志,2020,49(7):907.[doi:DOI:10.3969/j.issn.10007377.2020.07.038]
AI Dingding,LUO Weisheng,JIANG Yunxia..Progress in the establisment of animal liver fibrosis model[J].,2020,49(6):907.[doi:DOI:10.3969/j.issn.10007377.2020.07.038]